Company

Curetis AG develops

next level molecular

diagnostic solutions.

Technology

Proven and innovative technologies to deliver clinically relevant information on time.

The Unyvero System -

fast & reliable infectious

disease testing.

Boost your career at a highly innovative molecular diagnostics company.

22.04.2013 Curetis raises EUR 12.5 million in Series B round led by new investor HBM Partnersread more

17.04.2013 Curetis to Present Clinical Unyvero™ Data at ECCMID 2013 in Berlinread more

13.11.2013 BIT´s 3rd Annual Congress of MolMed 2013, Hainan International Convention and Exhibition Center, China - 13 to 16 November, 2013

02.10.2013 8th European Meeting on Molecular Diagnostics, Scheveningen The Hague, Netherlands - 2 to 4 October, 2013

Product Video

Visualize
the Unyvero^TM
Pneumonia Application >